Sex differences in tuberculosis incidence: a pooled analysis of 11 prospective cohort studies
Yohhei Hamada, Sujen Surenthirarajah, Rishi K Gupta, Matteo Quartagno et autres
0 citationsEClinicalMedicine
Matteo Quartagno
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
115Publications signalées
2254Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Statistical Methods and Bayesian InferenceStatistical Methods in Clinical TrialsAdvanced Causal Inference TechniquesTuberculosis Research and EpidemiologyStatistical Methods and Inference
Publications récentes
Sample Size Calculation for the ROCI Design
Henry Bern, James Carpenter, Mahesh Parmar, Ian R. White et autres
0 citationsStatistics in Medicine
How to design a ROCI (Response Over Continuous Intervention) randomised trial: guidance and a case study
Matteo Quartagno, Ehsan Ghorani, Tim P. Morris, Henry Bern et autres
0 citationsBMC Medical Research Methodology
Sex Differences in Tuberculosis Incidence: A Pooled Analysis of 11 Prospective Cohort Studies
Yohhei Hamada, Sujen Surenthirarajah, Rishi K. Gupta, Matteo Quartagno et autres
0 citationsSSRN Electronic Journal
Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trial
Lisanne A. H. Bevers, Gabriela Toledo, Muzamil Kisekka, Isabelle Déprez et autres
3 citationsEBioMedicine
Temporal Trends in Sexual Identity and Sociodemographic Disparities in Stockholm, Sweden, 2010–2021
Per Tynelius, Maya B. Mathur, Matteo Quartagno, Gunnar Brandén et autres
0 citationsAmerican Journal of Public Health
3169eP Relative vs absolute non-inferiority margins in survival analysis: A simulation study on hazard ratios and restricted mean survival time
A. Richters, Annemiek van Ommen‐Nijhof, Matteo Quartagno, Gabe S. Sonke et autres
0 citationsAnnals of Oncology
Designing a response-over-continuous-intervention (ROCI) randomised trial: Implementation in the Phase 2C part (duration ranging) of the PARADIGM4TB trial
Tra My Pham, Angela M. Crook, Katie Rolfe, Patrick Phillips et autres
2 citationsContemporary Clinical Trials
Tackling control risk problems in non-inferiority trials
Ian R. White, Matteo Quartagno, Abdel G. Babiker, Rebecca Turner et autres
1 citationBMJ Medicine
Summary measures in non-inferiority clinical trials with a time-to-event outcome: an empirical comparison of power
Shole D.L. Broer, Ian R. White, Tim P. Morris, Isabelle R. Weir et autres
0 citationsBMC Medical Research Methodology
Determining the optimal use of approved drugs in oncology
Gauthier Bouche, Duncan C. Gilbert, Matteo Quartagno, Hakim-Moulay Dehbi et autres
4 citationsThe Lancet Oncology
Summary measures in non-inferiority clinical trials with a time-to-event outcome: an empirical comparison of power
Shole D.L. Broer, Ian R. White, Tim P. Morris, Isabelle R. Weir et autres
0 citationsResearch Square
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.